Antibody-mediated PSGL-1 blockade increased the proinflammatory response of human macrophages in isolation as well as in complex model systems such as patient-derived tumor cultures and in syngeneic murine models as well as a humanized mouse melanoma model. This evidence concerns the gene SELPLG and neoplasm.